Global Biosimilar Testing Service Market Opportunities and Forecast 2022-2028
Report Code: KNJ1243957 No. of Pages: 132 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report provides a comprehensive analysis of current global Biosimilar Testing Service market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Biosimilar Testing Service industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to this survey, the global Biosimilar Testing Service market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Biosimilar Testing Service Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Biosimilar Testing Service market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global Biosimilar Testing Service Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Biosimilar Testing Service industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Pharmacokinetic Assay
Tiered Immunogenicity Testing
Others
Segmented by Application
Hospitals
Pharmaceutical Companies
Others
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
SGS
Sartorius
Profacgen
PPD
Pacific BioLabs
Merck
Medicilon
LAB Holdings
Kymos Pharma Services
Intertek
Eurofins Scientific
Charles River Laboratories International
Antibody Analytics
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Biosimilar Testing Service Market Status and Forecast (2017-2028)
1.3.2 Global Biosimilar Testing Service Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Biosimilar Testing Service Supply by Company
2.1 Global Biosimilar Testing Service Sales Value by Company
2.2 Biosimilar Testing Service Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Biosimilar Testing Service Market Status by Type
3.1 Biosimilar Testing Service Type Introduction
3.1.1 Pharmacokinetic Assay
3.1.2 Tiered Immunogenicity Testing
3.1.3 Others
3.2 Global Biosimilar Testing Service Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Biosimilar Testing Service Market Status by Application
4.1 Biosimilar Testing Service Segment by Application
4.1.1 Hospitals
4.1.2 Pharmaceutical Companies
4.1.3 Others
4.2 Global Biosimilar Testing Service Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Biosimilar Testing Service Market Status by Region
5.1 Global Biosimilar Testing Service Market by Region
5.2 North America Biosimilar Testing Service Market Status
5.3 Europe Biosimilar Testing Service Market Status
5.4 Asia Pacific Biosimilar Testing Service Market Status
5.5 Central & South America Biosimilar Testing Service Market Status
5.6 Middle East & Africa Biosimilar Testing Service Market Status
6 North America Biosimilar Testing Service Market Status
6.1 North America Biosimilar Testing Service Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Biosimilar Testing Service Market Status
7.1 Europe Biosimilar Testing Service Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Biosimilar Testing Service Market Status
8.1 Asia Pacific Biosimilar Testing Service Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Biosimilar Testing Service Market Status
9.1 Central & South America Biosimilar Testing Service Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Biosimilar Testing Service Market Status
10.1 Middle East & Africa Biosimilar Testing Service Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Biosimilar Testing Service Market Forecast by Type and by Application
12.1 Global Biosimilar Testing Service Sales Value Forecast (2023-2028)
12.2 Global Biosimilar Testing Service Forecast by Type
12.3 Global Biosimilar Testing Service Forecast by Application
13 Global Biosimilar Testing Service Market Forecast by Region/Country
13.1 Global Biosimilar Testing Service Market Forecast by Region (2023-2028)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 SGS
14.1.1 Company Information
14.1.2 Biosimilar Testing Service Product Introduction
14.1.3 SGS
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.1.4 SWOT Analysis
14.2 Sartorius
14.2.1 Company Information
14.2.2 Biosimilar Testing Service Product Introduction
14.2.3 Sartorius
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.2.4 SWOT Analysis
14.3 Profacgen
14.3.1 Company Information
14.3.2 Biosimilar Testing Service Product Introduction
14.3.3 Profacgen
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.3.4 SWOT Analysis
14.4 PPD
14.4.1 Company Information
14.4.2 Biosimilar Testing Service Product Introduction
14.4.3 PPD
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.4.4 SWOT Analysis
14.5 Pacific BioLabs
14.5.1 Company Information
14.5.2 Biosimilar Testing Service Product Introduction
14.5.3 Pacific BioLabs
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.5.4 SWOT Analysis
14.6 Merck
14.6.1 Company Information
14.6.2 Biosimilar Testing Service Product Introduction
14.6.3 Merck
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.6.4 SWOT Analysis
14.7 Medicilon
14.7.1 Company Information
14.7.2 Biosimilar Testing Service Product Introduction
14.7.3 Medicilon
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.7.4 SWOT Analysis
14.8 LAB Holdings
14.8.1 Company Information
14.8.2 Biosimilar Testing Service Product Introduction
14.8.3 LAB Holdings
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.8.4 SWOT Analysis
14.9 Kymos Pharma Services
14.9.1 Company Information
14.9.2 Biosimilar Testing Service Product Introduction
14.9.3 Kymos Pharma Services
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.9.4 SWOT Analysis
14.10 Intertek
14.10.1 Company Information
14.10.2 Biosimilar Testing Service Product Introduction
14.10.3 Intertek
Biosimilar Testing Service Sales Value, Gross Margin and Global Share (2020-2022)
14.10.4 SWOT Analysis
14.11 Eurofins Scientific
14.12 Charles River Laboratories International
14.13 Antibody Analytics
15 Conclusion
16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com